Clene Provides Update on ALS Clinical Development Meeting With FDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/27/2026

1. NVDA
2. MPLT
3. USO
4. BSP
5. XFLT
6. HCA
7. ITG
8. CAPR
9. SPY
10. LIME

Go back to Clene Provides Update on ALS Clinical Development Meeting With FDA
(NASDAQ: CLNN) Delayed: 5.46 +0.07 (1.30%)
Previous Close $5.39    52 Week High $ 
Open $5.39    52 Week Low $ 
Day High $5.47    P/E N/A 
Day Low $5.29    EPS $ 
Volume 28,082